REGN Reports Encouraging Data on Gene Therapy for Genetic Hearing Loss (Revised)
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study. This gene therapy...
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study. This gene therapy...
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study.This gene therapy is...
A gene-editing approach called prime editing could one day help treat many illnesses by turning faulty genes into healthy ones....
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study.This gene therapy is...
Opus Genetics, Inc. released positive data from a pediatric cohort in an ongoing phase 1/2 clinical study evaluating OPGx-LCA5, an...
Researchers have found a promising new method for gene therapy. They successfully restarted inactive genes by bringing them closer to...
The "Cell Biology Research Market, Global, 2024-2030" report has been added to ResearchAndMarkets.com's offering. The revenue estimate for the base...
UK researchers say they have slowed the progression of the fatal neural condition Huntington's disease for the first time with...
Yilong Zhou, a visiting undergraduate student from Tsinghua University, used CRISPR-GPT to successfully active genes in A375 melanoma cancer cells...